ADVIL DUAL ACTION WITH ACETAMINOPHEN
Clinical safety rating: caution
Comprehensive clinical and safety monograph for ADVIL DUAL ACTION WITH ACETAMINOPHEN (ADVIL DUAL ACTION WITH ACETAMINOPHEN).
Ibuprofen is a nonsteroidal anti-inflammatory drug (NSAID) that inhibits cyclooxygenase (COX-1 and COX-2) enzymes, reducing prostaglandin synthesis. Acetaminophen is an analgesic and antipyretic whose mechanism is not fully understood but involves inhibition of cyclooxygenase in the central nervous system and modulation of the endocannabinoid system.
| Metabolism | Ibuprofen is primarily metabolized by CYP2C9. Acetaminophen is mainly metabolized by conjugation (glucuronidation and sulfation) and to a minor extent by CYP2E1 and CYP3A4. |
| Excretion | Ibuprofen: renal (90% as metabolites and conjugates, <10% unchanged); Acetaminophen: renal (85% as sulfate and glucuronide conjugates, 4% unchanged, 9% as cysteine and mercapturic acid conjugates; minor biliary). |
| Half-life | Ibuprofen: 2-4 hours; Acetaminophen: 2-3 hours. Clinical context: Short half-lives require dosing every 6-8 hours. Extended half-life in overdose (acetaminophen >4 hours indicates toxicity). |
| Protein binding | Ibuprofen: >99% bound to albumin; Acetaminophen: 10-25% bound (minimal). |
| Volume of Distribution | Ibuprofen: 0.15 L/kg (low, reflects high protein binding); Acetaminophen: 0.9 L/kg (widely distributed to tissues). |
| Bioavailability | Oral: Ibuprofen 80-90%, Acetaminophen 85-95%. |
| Onset of Action | Oral: Ibuprofen ~30 min (analgesic), 1-2 hours (anti-inflammatory); Acetaminophen ~30 min (analgesic/antipyretic). |
| Duration of Action | Ibuprofen: 4-6 hours (analgesic); Acetaminophen: 4-6 hours (analgesic/antipyretic). Clinical note: Duration sufficient for acute pain; chronic use may require scheduling. |
| Molecular Weight | Ibuprofen: 206.28 Da; Acetaminophen: 151.16 Da |
One caplet (ibuprofen 250 mg and acetaminophen 500 mg) orally every 8 hours while symptoms persist; maximum: 3 caplets per day.
| Dosage form | TABLET |
| Renal impairment | Acetaminophen: no dose adjustment for GFR > 30 mL/min; use with caution at GFR 10-30 mL/min (extend interval to 6-8 hours); avoid if GFR < 10 mL/min. Ibuprofen: avoid if eGFR < 30 mL/min (risk of acute kidney injury); no dose adjustment for eGFR ≥ 30 mL/min. |
| Liver impairment | Acetaminophen: Child-Pugh A (mild): no adjustment; Child-Pugh B (moderate): reduce total daily dose to max 2 g; Child-Pugh C (severe): contraindicated. Ibuprofen: Child-Pugh A and B: no adjustment (use lowest effective dose); Child-Pugh C: avoid (risk of gastrointestinal bleeding and hepatorenal syndrome). |
| Pediatric use | Not approved for children < 12 years. For children ≥12 years: same as adult dose (250 mg ibuprofen and 500 mg acetaminophen) orally every 8 hours; maximum 3 caplets/day. |
| Geriatric use | Use lowest effective dose for shortest duration. Consider total acetaminophen intake (max 3 g/day in elderly) due to reduced hepatic reserve. Ibuprofen may increase GI bleeding risk; consider proton pump inhibitor co-therapy. Baseline renal function should be monitored; avoid if eGFR < 30 mL/min. |
| 1st trimester | Avoid; ibuprofen and acetaminophen combination not well studied in first trimester; ibuprofen associated with increased risk of miscarriage and congenital anomalies; acetaminophen generally considered safer but long-term use linked to ADHD risk. |
| 2nd trimester | Use with caution; ibuprofen may cause oligohydramnios and premature ductus arteriosus constriction; acetaminophen preferred for pain/fever; combination not recommended. |
| 3rd trimester | Avoid; ibuprofen contraindicated due to risk of premature closure of ductus arteriosus, oligohydramnios, and neonatal complications; acetaminophen acceptable but combination not advised. |
Clinical note
Comprehensive clinical and safety monograph for ADVIL DUAL ACTION WITH ACETAMINOPHEN (ADVIL DUAL ACTION WITH ACETAMINOPHEN).
| Placental transfer | Both ibuprofen and acetaminophen cross the placenta; ibuprofen transfer is limited but reaches fetal circulation; acetaminophen readily crosses with fetal concentrations similar to maternal. |
| Breastfeeding |
■ FDA Black Box Warning
NSAIDs cause an increased risk of serious cardiovascular thrombotic events, including myocardial infarction and stroke, which can be fatal. This risk may increase with duration of use. NSAIDs are contraindicated in the setting of coronary artery bypass graft (CABG) surgery.
| Serious Effects |
Third trimester of pregnancy (due to ibuprofen's risk of premature ductus arteriosus closure and oligohydramnios)History of anaphylactic reaction or severe hypersensitivity to NSAIDs or acetaminophenActive peptic ulcer disease or gastrointestinal bleedingSevere hepatic impairment (acetaminophen component)Severe renal impairment (creatinine clearance <30 mL/min for ibuprofen)Concomitant use of other NSAIDs or acetaminophen-containing products (risk of hepatotoxicity and GI effects)Aspirin-sensitive asthma (due to ibuprofen)
| Precautions | Risk of serious cardiovascular events, gastrointestinal bleeding/ulceration/perforation, renal toxicity, hepatic toxicity (especially with acetaminophen overdose), anaphylactoid reactions, and hypertension. |
| Food/Dietary |
Loading safety data…
| Ibuprofen and acetaminophen are excreted into breast milk in low amounts; ibuprofen levels are minimal and considered compatible with breastfeeding; acetaminophen also safe. However, combination product safety not specifically studied; avoid prolonged use or high doses. Monitor infant for rash, drowsiness, or gastrointestinal effects. |
| Lactation Rating | L2 - Safer (for individual components; combination not rated) |
| Teratogenic Risk | First trimester: Ibuprofen (NSAID) is associated with increased risk of spontaneous abortion and cardiac defects; acetaminophen is generally considered low risk but some studies suggest increased risk of gastroschisis. Second trimester: Ibuprofen may cause oligohydramnios and fetal renal dysfunction; acetaminophen appears safe at therapeutic doses. Third trimester: Ibuprofen should be avoided due to risk of premature closure of ductus arteriosus, oligohydramnios, and necrotizing enterocolitis; acetaminophen is preferred for pain/fever. |
| Fetal Monitoring | Monitor amniotic fluid volume (oligohydramnios risk with NSAIDs), fetal echocardiography for ductus arteriosus patency (third trimester), renal function (maternal serum creatinine, BUN), and signs of premature labor. For acetaminophen: monitor liver function if high doses or prolonged use. |
| Fertility Effects | Ibuprofen may inhibit ovulation by suppressing prostaglandin synthesis, potentially reversible. Acetaminophen has no known significant effect on fertility at therapeutic doses. |
| Avoid alcohol consumption due to increased risk of hepatotoxicity from acetaminophen. Taking with food or milk can reduce gastrointestinal irritation. Grapefruit juice may alter metabolism of ibuprofen; limit intake. High-fat meals may delay absorption but does not require specific restriction. |
| Clinical Pearls | Advil Dual Action combines ibuprofen (NSAID) and acetaminophen (paracetamol) for synergistic analgesia. Monitor renal function in elderly or dehydrated patients due to NSAID component. Avoid in patients with peptic ulcer disease or bleeding diathesis. Acetaminophen hepatotoxicity risk increases with alcohol use or pre-existing liver disease; do not exceed 4000 mg/day acetaminophen total from all sources. |
| Patient Advice | Do not take this medication with other products containing acetaminophen to avoid liver damage. · Take with food or milk to reduce stomach upset. · Avoid alcohol while taking this medication. · Stop use and consult doctor if symptoms worsen or new symptoms occur. · Do not use for more than 10 days for pain or 3 days for fever unless directed by a doctor. · Store at room temperature away from moisture and heat. |